Darren Carpizo
Chief, Division of Surgical Oncology · University of Rochester Medical Center
Credentials: · · · · · ·
History
- Present
Division of Surgical Oncology · University of Rochester Medical Center
- Present
Basic/Translational Research · University of Rochester Medical Center
- Present
Genetics · Wilmot Cancer Institute
2021–2025
University of California Los Angeles Medical Center.
Research
The Journal of Cell Biology · 2005 · 560 citations
Allele-specific p53 mutant reactivation
Cancer Cell · 2012 · Last of 4 authors · Corresponding · 282 citations
ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165
Journal of Biological Chemistry · 2003 · 206 citations
19 papers · 6 as a fellow
17 papers
- DA
13 papers
13 papers
11 papers
- AC
10 papers · 9 as a resident
8 papers
- AB
7 papers · 2 as a resident
Grants
- 2026–2031
The Role of Circadian Gene Regulation in Pancreatic Cancer Progression and Immune Evasion
National Cancer Institute · U01
Contact PI · $626.6K · University of Rochester
- 2025–2030
Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer
National Cancer Institute · R01
PI · $1.3M · University of Rochester
- 2025–2030
University of Rochester Wilmot Cancer Institute Support Grant
National Cancer Institute · P30
Project lead · $40.8K · University of Rochester
- 2016–2022
Development of Zinc Metallochaperones as Mutant p53 Targeted Anti-cancerDrugs
National Cancer Institute · R01
Contact PI · $1.9M · University of Rochester
Clinical trials
- 2012–2014
A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer
Principal investigator · Withdrawn · Early phase 1
Rutgers, The State University of New Jersey
- 2020–2030
Pancreatic Cancer Early Detection Consortium
Site PI · Recruiting
Arbor Research Collaborative for Health